Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy
- 1 June 2001
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 308 (1-2) , 33-41
- https://doi.org/10.1016/s0009-8981(01)00423-5
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- PHARMACOGENETICS: GENOTYPING OF CYTOCHROMES P450 2D6 AND 2C19 IN PSYCHIATRIC PATIENTS TREATED WITH TRICYCLIC ANTIDEPRESSANTS (TCA) OR NEUROLEPTICS.Therapeutic Drug Monitoring, 1999
- Population studies of polymorphisms of the serotonin transporter protein geneAmerican Journal of Medical Genetics, 1999
- Therapeutic Drug Monitoring of AntidepressantsClinical Pharmacokinetics, 1999
- Pharmacogenetics of antidepressants: clinical aspectsActa Psychiatrica Scandinavica, 1997
- Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolutionPharmacogenetics, 1997
- Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory RegionScience, 1996
- Allelic Variation of Human Serotonin Transporter Gene ExpressionJournal of Neurochemistry, 1996
- Organization of the human serotonin transporter geneJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
- Clinical Pharmacokinetics of Selective Serotonin Reuptake InhibitorsClinical Pharmacokinetics, 1993
- Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquineThe Lancet, 1993